112 related articles for article (PubMed ID: 7925818)
1. Calcineurin immunoreactivity in Alzheimer's disease.
Billingsley ML; Ellis C; Kincaid RL; Martin J; Schmidt ML; Lee VM; Trojanowski JQ
Exp Neurol; 1994 Apr; 126(2):178-84. PubMed ID: 7925818
[TBL] [Abstract][Full Text] [Related]
2. Tau phosphorylation in brain slices: pharmacological evidence for convergent effects of protein phosphatases on tau and mitogen-activated protein kinase.
Garver TD; Oyler GA; Harris KA; Polavarapu R; Damuni Z; Lehman RA; Billingsley ML
Mol Pharmacol; 1995 Apr; 47(4):745-56. PubMed ID: 7723735
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin (phosphatase 2B) is present in neurons containing neurofibrillary tangles and in a subset of senile plaques in Alzheimer's disease.
Brion JP; Couck AM; Conreur JL
Neurodegeneration; 1995 Mar; 4(1):13-21. PubMed ID: 7600182
[TBL] [Abstract][Full Text] [Related]
4. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
Papasozomenos SC
Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
[TBL] [Abstract][Full Text] [Related]
5. Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex.
Lian Q; Ladner CJ; Magnuson D; Lee JM
Exp Neurol; 2001 Jan; 167(1):158-65. PubMed ID: 11161603
[TBL] [Abstract][Full Text] [Related]
6. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
8. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
Mukaetova-Ladinska EB; Harrington CR; Roth M; Wischik CM
Am J Pathol; 1993 Aug; 143(2):565-78. PubMed ID: 8342603
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
Gómez-Ramos P; Morán MA
Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
[TBL] [Abstract][Full Text] [Related]
11. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
[TBL] [Abstract][Full Text] [Related]
12. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
14. Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease.
Kowall NW; Kosik KS
Ann Neurol; 1987 Nov; 22(5):639-43. PubMed ID: 3122646
[TBL] [Abstract][Full Text] [Related]
15. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY
Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017
[TBL] [Abstract][Full Text] [Related]
16. Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex.
Mawal-Dewan M; Schmidt ML; Balin B; Perl DP; Lee VM; Trojanowski JQ
J Neuropathol Exp Neurol; 1996 Oct; 55(10):1051-9. PubMed ID: 8858002
[TBL] [Abstract][Full Text] [Related]
17. Hyperphosphorylation of tau and protein phosphatases in Alzheimer disease.
Liu F; Liang Z; Gong CX
Panminerva Med; 2006 Jun; 48(2):97-108. PubMed ID: 16953147
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.
Schneider A; Biernat J; von Bergen M; Mandelkow E; Mandelkow EM
Biochemistry; 1999 Mar; 38(12):3549-58. PubMed ID: 10090741
[TBL] [Abstract][Full Text] [Related]
19. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
Pei JJ; Sjögren M; Winblad B
Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
[TBL] [Abstract][Full Text] [Related]
20. DSCR1(Adapt78)--a Janus gene providing stress protection but causing Alzheimer's disease?
Ermak G; Davies KJ
IUBMB Life; 2003 Jan; 55(1):29-31. PubMed ID: 12716059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
